Orexo announces prospering completion of OX219 first pharmacokinetic trial for opioid dependenceOrexo AB announces self-made completion of the first pharmacokinetic trial in the OX219 project. In the relative bioavailability study, the OX219 buprenorphine/naloxone sublingual tablet formulation manifested favourable profiles gone to the comparator Suboxone®, which is the market entailing product for treatment of opioid dependence.Read [...]
dependence's tag archives
Orexo announces successful completion of OX219 initial pharmacokinetic trial for opioid dependence
Posted by admin in December 15th 2010
RSS
Articles
-
- Tips To Know When Selecting Your Web Host
- Common Mistakes To Avoid In Personal Development
- Brightening The World With Green Energy
- Simple Changes You Can Make For A Greener Home
- The Many Advantages Of A Solar Energy System For Your Home
- Picking A Web Host That You Can Count On
- Avoid These Complications When Choosing A Web Hosting Company
- Make These Important Changes In Your Appliance Use
- Using Green Energy To Reduce Your Reliance On Non-Renewable Resources
- Making Any Home More Energy Efficient
- Are They a Bad Web Host?
- Six Helpful Web Hosting Tips
- Top Five Personal Development Tips
- How to Use Personal Development to Reach True Success
- Finding Ways To Reduce Energy Consumption And Cost
